AMBER KIRK: Open Payments
NPI 1447752209 · ASHLAND, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$916 in 40 payments from 15 companies in 2025. Trend: 2023 $575 · 2024 $1,123 · 2025 $916
Food & beverage: $916
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $305 |
| Otsuka America Pharmaceutical, Inc. | 7 | $145 |
| Calliditas Therapeutics US Inc. | 6 | $103 |
| Vifor Pharma, Inc. | 2 | $64 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $54 |
| Travere Therapeutics, Inc. | 2 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $50 |
| Philips North America LLC | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Alexion Pharmaceuticals, Inc. | 1 | $19 |
Products named: Kerendia, JYNARQUE, TARPEYO, JARDIANCE, Veltassa, CAPLYTA, VOYXACT, Vest Therapy Und.
Industry payments across KY — which companies pay providers there.
